Latest News & Features
Big Pharma
Ahead of the IQPC - Life Science IP conference in London, Kevin Mooney, chairman of the rules and procedure committee at the UPC, answers pressing questions on the IP landscape post-Brexit and the future of the Europe-wide patents court project. 25 November 2019
Big Pharma
Swiss drug company Novartis has agreed to buy The Medicines Co for $9.7 billion, as it focuses on expanding its cardiovascular portfolio. 25 November 2019
Biotechnology
The US Department of Justice has charged a former Monsanto employee with committing economic espionage and trade secrets theft. 22 November 2019
Generics
Russian drug patent owners are being forced to come up with novel solutions to combat generic manufacturers trying to clear the way for competitor medicines. 21 November 2019
Biotechnology
The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system. 21 November 2019
Big Pharma
English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21. 21 November 2019
Big Pharma
A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck. 21 November 2019
Generics
US presidential candidates Bernie Sanders and Cory Booker have tabled a bill that would force drug companies to adhere to government-set prices-or risk losing patent exclusivity. 21 November 2019
Big Pharma
The Swiss Federal Institute of Intellectual Property has failed to stop an Indian pharmaceutical and medicine wholesaler from registering the trademark ‘Swisslife Forever’ at the UK Intellectual Property Office. 19 November 2019
Generics
The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies. 19 November 2019